Skip to main content

Table 1 The basic characteristics of patients with proliferative diabetic retinopathy received with an intravitreous injection of ranibizumab

From: Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy

Characteristics

Patients in all

Patients who developed ghost cell glaucoma

Patients failed to develop ghost cell glaucoma

Correlations with the presence of post-vitreous injection ghost cell glaucoma (p-value)

age (y, mean ± SD)

51.46 ± 11.26

47.85 ± 12.05

51.92 ± 11.11

0.34

gender (male, n, %)

41, 57.75%

5, 62.5%

36,57.1%

0.77

duration of diabetes mellitus (y, mean ± SD)

10.00 ± 6.69

9.2 ± 6.2

9.5 ± 6.8

0.92

onset of vision decrease (m, median, 1st Qu, 3rdQu)

5.38 ± 4.77

3.63 ± 2.13

5.60 ± 4.97

0.35 a

use of insulin (y, n, %)

47, 66.20%

6, 75%

41,65.1%

0.57

history of retinal photocoagulation (y, n, %)

42, 59.15%

7, 87.5%

35, 55.5%

0.084

(7/42 vs 1/29

Laser point p < 0.001)

refraction error

   

0.67

myopia (n,%)

10, 14.1%

1,12.5%

9, 14.2%

 

emmetropia (n,%)

57, 80.3%

6, 75.0%

51, 81%

 

hyperopia (n,%)

4, 5.6%

1,12.5%

3, 4.8%

 

presence of iris neovascular (n, %)

8, 11.3%

3, 37.5%

3, 4.8%

< 0.001

presence of dense vitreous hemorrhage (n, %)

70, 98.59%

8, 100%

62, 98.4%

0.72

presence of tractional retinal detachment (n, %)

58, 81.7%

3, 37.5%

55, 87.3%

< 0.001

Trd 11.3% non-trd 88.7

presence of PVD (n, %)

15, 21.1%

1, 12.5%

14, 22.2%

0.53

presence of fibromembrane involving disk (n, %)

40, 56.3%

6, 75%

34, 54%

0.25

11.3 vs 88.7

BCVA

   

0.72

LP ~ <=0.01 (n, %)

32, 45.07%

6, 75%

26, 41.3%

 

0.01 ~ <=0.1 (n, %)

31, 43.66%

2, 25%

29, 46.0%

 

0.1 ~ <=0.5 (n, %)

6, 8.45%

0

6, 9.5%

 

> 0.5 (n, %)

2, 2.82%

0

2, 3.2%

 

Pseudophakic eye (n, %)

3, 4.2%

1, 12.5%

2, 3.2%

0.22

axial length (mm, mean ± SD)

22.89 ± 0.75

23.09 ± 0.52

22.88 ± 0.78

0.46

silicon tamponade (n, %)

20, 28.2%

2, 25%

18, 28.6%

0.83

photocoagulation burns during vitrectomy (points, median, 1st Qu, 3rdQu)

1046, 535, 1382

660,303,1023

1074, 588, 1382

0.18

prescence of macular edema (n, %)

28, 39.4%

4, 50%

24, 38.1%

0.52

tractional retinal detachment involving macular (n, %)

16, 22.5%

1, 12.5%

15,23.8%

0.47

Interval between

3, 2,4

4,2,6

3,2,4

0.36

IVR and vitrectomy (d, median, 1st Qu, 3rdQu)

    

<=2 d (n, %)

21, 29.58%

2, 25%

19, 30.2%

 

2 ~ <=5d (n, %)

39, 54.93%

3, 37.5%

36, 57.1%

 

>5d (n, %)

11, 15.49

3, 37.5%

8, 12.7%

 
  1. a Wilcoxon rank sum test